The sanofi-aventis Group is one of the world's largest pharmaceutical company, ranked number one in Europe. Backed by a world-class Research & Development organization, sanofi-aventis is developing leading positions in seven major therapeutic areas: cardiovascular disease, thrombosis, oncology, metabolic diseases, central nervous system, internal medicine, and vaccines. Sanofi pasteur, the vaccines division of the sanofi-aventis Group, provided more than 1.6 billion doses of vaccine in 2007, making it possible to immunize more than 500 million people across the globe. A world leader in the vaccine industry, sanofi pasteur offers the broadest range of vaccines, providing protection against 20 infectious diseases.
J .Mark Lievonen, President
Date de la fin du dernier exercice financier complet : 2007-12-31
Institution gouvernementale | Financement reçu au cours du dernier exercice financier | Financement attendu pendant l'exercice financier en cours |
---|---|---|
Industry Canada, Technology Partnerships Canada (TPC) | 1 378 011,00 $ | Oui |
Ontario Ministry of Research and Innovation | 0,00 $ | Oui |
Adresse :
1755 Steeles Avenue West
Toronto, ON M2R 3T4
Canada
Numéro de téléphone :
416-667-2760
Numéro de fax :
416-667-2977